Hydrofarm Holdings Group, Inc. — Q2 2022 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2022. Hydrofarm manufactures and distributes controlled-environment agriculture equipment and supplies, primarily in the U.S. and Canada, and reports as one segment. Unless otherwise stated, amounts below are in U.S. dollars.
Financial performance
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Net sales | $97.5 million | $133.8 million | $208.9 million | $245.2 million |
| Gross profit / margin | $7.3 million / 7.5% | $29.6 million / 22.1% | $23.9 million / 11.5% | $52.8 million / 21.5% |
| Operating income (loss) | $(208.2) million | $2.3 million | $(234.6) million | $8.7 million |
| Net income (loss) | $(203.3) million | $2.3 million | $(226.6) million | $7.2 million |
| Adjusted EBITDA (non-GAAP) | $(6.8) million | $16.2 million | $(3.8) million | $26.1 million |
- Q2 sales fell 27.1%; first-half sales fell 14.8%. Management attributed the declines primarily to lower product volumes amid agricultural oversupply and reduced cannabis growing activity. Acquired brands partly offset organic sales declines; pricing and mix also improved.
- Gross margin contracted sharply, reflecting higher inventory-obsolescence reserves—$10.2 million in Q2 and $13.4 million in the first half, primarily for lighting products—as well as freight and labor costs that were higher relative to sales.
- Q2 included a $189.6 million noncash goodwill impairment, reducing goodwill to zero. The first-half impairment total was $192.3 million, including a $2.6 million impairment of a note receivable in Q1. No intangible-asset impairment was recorded in Q2.
- First-half SG&A was $66.2 million, up $22.1 million year over year, including higher amortization, compensation, stock-based compensation, facility and relocation costs. Q2 SG&A declined 4.7% to $26.0 million, partly because acquisition and integration costs were lower.
Cash flow, balance sheet and liquidity
- First-half operating cash flow was $7.3 million, versus cash used of $0.5 million a year earlier, supported by working-capital reductions, including lower inventory and receivables. Investing cash outflow was $4.7 million, mainly capital spending; financing cash outflow was $3.3 million. Cash, cash equivalents and restricted cash totaled $27.4 million at June 30.
- At June 30, cash and cash equivalents were $26.4 million and restricted cash was $1.0 million. Current assets were $227.1 million and current liabilities $71.4 million. Inventory was $157.3 million, down from $189.1 million at year-end 2021.
- Debt totaled $121.1 million carrying value, including a $124.4 million term-loan principal balance. The loan matures in October 2028; its interest rate was locked at 8.38% through December 30, 2022. The $100 million asset-based revolver had no borrowings and approximately $70 million of borrowing availability. The company reported compliance with debt covenants.
- Management said cash, operating cash flow and borrowing availability should fund operations, debt service and other needs for the next 12 months. It was also evaluating sales/leasebacks, asset sales and equity financing as possible contingency measures if needed. Aurora contingent consideration of $15.3 million was paid in July 2022.
Outlook, commentary and risks
- The filing provides no specific revenue, earnings or margin guidance. Management said the duration and impact of current market conditions were uncertain and difficult to predict.
- Management cited agricultural oversupply, weaker customer demand, macroeconomic and industry conditions, and lower cannabis-related growing activity. It reduced manufacturing and production and implemented temporary furloughs; these actions could continue.
- Further inventory write-downs or impairment charges remain possible. The company identified inventory forecasting and obsolescence, long-lived asset valuations, supply-chain lead times and costs, interest-rate exposure, and customer and crop-market conditions as relevant risks.
- At June 30, $124.4 million of debt was variable-rate exposure; management estimated a 100-basis-point rate increase would raise annual interest expense by about $1.2 million. The company reported no material legal proceedings expected to adversely affect it.
Key facts for investors to verify
- Whether demand and sales volumes stabilize, and whether inventory levels and obsolescence reserves adequately reflect future demand.
- Whether gross margins recover as reserve charges, freight and labor pressures change.
- Whether cash generation and the approximately $70 million revolver availability remain sufficient, particularly after the July contingent-consideration payment.
- Whether the company remains in compliance with loan covenants and how interest rates affect debt service.
- Whether further impairment or inventory charges arise; goodwill was fully written off, while $313.5 million of net intangible assets remained at quarter-end.